Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
SAN FRANCISCO, CA--(Marketwired - August 12, 2016) - After five years of a brutal bear market, gold and gold miners are finally having a huge rebound, and investor Chen Lin, writer of the popular...
-
VIENNA, VA--(Marketwired - August 04, 2016) - Eric Heflin, CIO/CTO for The Sequoia Project, has been elected to the IHE USA Board of Directors. IHE USA represents the United States' interests within...
-
VANCOUVER, BRITISH COLUMBIA--(Marketwired - July 29, 2016) - Handa Copper Corporation ("Handa Copper" or the "Company") (TSX VENTURE:HEC) announces that it has agreed to settle an...
-
CARLSBAD, CA, Calif., July 27, 2016 (GLOBE NEWSWIRE) -- Nearly 25 years after the original debut of Marvel Masterpieces, Upper Deck recently released a new super premium Marvel Masterpieces trading...
-
SOUTH SAN FRANCISCO, Calif., July 21, 2016 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (Nasdaq:MATN), a biopharmaceutical company developing vascular disrupting agents (VDAs) for the treatment...
-
ATLANTA, June 30, 2016 (GLOBE NEWSWIRE) -- Smart lockers can drive sales and loyalty for ‘e-commerce stranded’ Locker locations can appear as a shipping address during checkout More than 8,000...
-
JERUSALEM, ISRAEL--(Marketwired - June 28, 2016) - An interview was held with Dr. Yair Auron, an Israeli historian and board member of the Zoryan Institute, after an article was released by The Times...
-
EDMONTON, ALBERTA--(Marketwired - June 21, 2016) - Alberta must confront the ugly - and dangerous - rhetoric that is directed at women in politics. At the organization's quarterly...
-
WATERTOWN, Mass., June 15, 2016 (GLOBE NEWSWIRE) -- athenahealth, Inc. (NASDAQ:ATHN), a leading provider of network-enabled services and mobile applications for healthcare providers nationwide,...
-
All four subjects received one-time administration of SPK-9001 at initial low dose for a cumulative 58-weeks of follow-up without the need for immunosuppression ...